| Literature DB >> 23670323 |
Rosângela Ghiringhelli1, Maria Cecilia Martinelli Iorio.
Abstract
UNLABELLED: Studies have shown that elderly people with cognitive impairments benefit more from hearing aids with slower recovery times.Entities:
Mesh:
Year: 2013 PMID: 23670323 PMCID: PMC9443837 DOI: 10.5935/1808-8694.20130032
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Parameters for LSP administration.
| Speech stimulus level | Variable speech stimulus levels |
|---|---|
| List of sentences used for practice | 1A |
| List of sentences: subject without hearing aids | 1B |
| List of sentences: subject with hearing aids | 2B |
| List of sentences in reassessment | 3B |
| Initial level of speech stimulus | 65 dB (A) |
| Noise level (constant) | 65 dB (A) |
| Increment for first sentences | 4 dB |
| Increment of sentences from mistake | 2 dB |
| Device maximum output | 120 dB |
Descriptive statistics for HHIE scale, before and after intervention, of the four sub-groups.
| Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| G1F | G1S | G2F | G2S | |||||
| Before | After | Before | After | Before | After | Before | After | |
| Mean | 57.33% | 15.00% | 61.83% | 16.83% | 69.69% | 25.38% | 71.38% | 26.15% |
| SD | 25.22% | 20.74% | 17.84% | 16.12% | 17.55% | 26.41% | 25.24% | 18.47% |
| n | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 |
G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices; SD: Standard deviation; n: number of subjects.
ANOVA results for the HHIE scale.
| Effects | |
|---|---|
| Group | 0.2227 |
| Stage | < 0.0001* |
| Group vs. Stage | 0.9904 |
Figure 1Differences between the pre and post-fitting stages in the HHIE scale. Confidence interval for the mean value: mean ± 1.96 * standard deviation/ . G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices.
Mean values and standard deviations for HHIE benefit analysis.
| Group | ||||
|---|---|---|---|---|
| G1F | G1S | G2F | G2S | |
| Mean | 42.33% | 45.00% | 44.31% | 45.23% |
| Standard deviation | 33.02% | 16.21% | 21.10% | 22.55% |
| n | 12 | 12 | 13 | 13 |
G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices; n: number of subjects; ** ANOVA (p) = 0.990.
Figure 2Analysis of benefit among groups in the HHIE scale. Confidence interval for the mean value: mean ± 1.96 * standard deviation/ . G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices.
Mean values and standard deviations for the four sub-groups before and after the ftting of hearing aids.
| Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| G1F | G1S | G2F | G2S | |||||
| Before | After | Before | After | Before | After | Before | After | |
| Mean | 4.456 | 2.611 | 5.041 | 3.000 | 8.068 | 5.603 | 4.811 | 3.212 |
| Standard deviation | 3.7716 | 2.7999 | 4.6764 | 3.4266 | 4.5389 | 4.1261 | 3.4959 | 2.7018 |
| n | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 13 |
G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices; n: number of subjects in group.
ANOVA results for the LSP test.
| Effects | |
|---|---|
| Group | 0.0529 |
| Stages | 0.0006* |
| Group vs. Stage | 0.9474 |
POST HOC for effect Group (LSP test).
| Frequency | G1F | G1S | G2F | G2S |
|---|---|---|---|---|
| G1F | - | - | - | - |
| G1S | 0.7146 | - | - | - |
| G2F | 0.0144* | 0.0354* | - | - |
| G2S | 0.7144 | 0.9944 | 0.0315* | - |
G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices; SD: Standard deviation.
Figure 3Differences between groups in the LSP test. Confdence interval for the mean value: mean ± 1.96 * standard deviation/ . G1F: Sub-group of subjects without cognitive impairment and fast release time devices; G1S: Sub-group of subjects without cognitive impairment and slow release time devices; G2F: Sub-group of subjects with cognitive impairment and fast release time devices; G2S: Sub-group of subjects with cognitive impairment and slow release time devices.